![(R)-(+)-7-[4(S)-(Benzyl)oxazol-2-yl]-7'-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-Ph-Bn-SIPHOX,（R)-(+)-7 -[4（S） -（苄基）恶唑- 2 -基] -7'-二苯基膦- 2，2,3,3四氢-1，1-螺二氢茚 , min. 97%](https://static.jkchemical.com/Structure/277/2772122.png)
（R)-(+)-7 -[4（S） -（苄基）恶唑- 2 -基] -7'-二苯基膦- 2，2,3,3四氢-1，1-螺二氢茚 , min. 97%
(R)-(+)-7-[4(S)-(Benzyl)oxazol-2-yl]-7'-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-Ph-Bn-SIPHOX
分子式: C??H??NOP
分子量: 563.67
纯度: min. 97%
| 包装 | 库存 | 价格 | |
|---|---|---|---|
暂无数据 | |||
推荐产品
基本信息
安全信息
化学和物理性质
产品描述
Technical Notes :
1. Chiral ligands for the iridium-catalyzed, asymmetric hydrogenation of imines .
2.Chiral ligands for the iridium-catalyzed, asymmetric hydrogenation of a-ß unsaturated carboxylic acids. 3.Chiral ligands for iridium-catalyzed, asymmetric hydrogenation of a,-oxy-a,ß-unsaturated carboxylic acids.
References:
1.J. Am. Chem. Soc., 2006, 128, 12886.
2. J. Am. Chem. Soc..2008, 130, 8584.
3.J. Am. Chem. Soc., 2010, 132, 1172.
